Joshua Savage

1.1k total citations
38 papers, 500 citations indexed

About

Joshua Savage is a scholar working on Psychiatry and Mental health, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joshua Savage has authored 38 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 11 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joshua Savage's work include Sexual function and dysfunction studies (13 papers), Genital Health and Disease (9 papers) and Lung Cancer Treatments and Mutations (5 papers). Joshua Savage is often cited by papers focused on Sexual function and dysfunction studies (13 papers), Genital Health and Disease (9 papers) and Lung Cancer Treatments and Mutations (5 papers). Joshua Savage collaborates with scholars based in United Kingdom, United States and Netherlands. Joshua Savage's co-authors include Alastair W. Poole, Landon Trost, Tobias Köhler, Matthew Ziegelmann, Lucinda Billingham, Robert Goggs, Matthew T. Harper, Christian H. Ottensmeier, Gary Middleton and Kristian Brock and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Joshua Savage

32 papers receiving 493 citations

Peers

Countries citing papers authored by Joshua Savage

Since Specialization

Citations

This map shows the geographic impact of Joshua Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Savage more than expected).

Fields of papers citing papers by Joshua Savage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Savage. The network helps show where Joshua Savage may publish in the future.

Co-authorship network of co-authors of Joshua Savage

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Savage. A scholar is included among the top collaborators of Joshua Savage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Savage. Joshua Savage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Responses can be achieved with a combination of the MEK inhibitor selumetinib and dexamethasone in patients with relapsed/refractory RAS-pathway mutated acute lymphoblastic leukemia: Results of a parallel cohort, dose-finding and expansion phase I/II trial 2026 ·University of Birmingham Research Portal (University of Birmingham) ·Britta Vormoor, Joshua Savage, (unknown), (unknown), (unknown), Geoff Shenton, (unknown), Anna Castleton, (unknown), (unknown), (unknown), Marion Strullu, Ruta Tuckuviene, Pamela Kearns, (unknown), S. Barnett, (unknown), (unknown), (unknown), Tobias Menne, Josef Vormoor	0
2	A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial 2024 ·BMC Cancer ·(unknown), Joshua Savage, Amit Patel, Fiona Collinson, (unknown), Florien Boele, Lucy Brazil, (unknown), Peter Buckle, Siân Lax, Lucinda Billingham, Susan Short	14
3	Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer 2024 ·PubMed ·Anthony Kong, Amanda Kirkham, Joshua Savage, (unknown), Siân Lax, James Good, Martin Förster, Joseph J. Sacco, (unknown), Kevin J. Harrington, Christina Yap, Hisham Mehanna	3
4	Impact of prednisone on vasectomy reversal outcomes (iPRED study): results from a randomized, controlled clinical trial 2024 ·Fertility and Sterility ·Landon Trost, Sevann Helo, (unknown), (unknown), Matthew Ziegelmann, Tobias Köhler, Joshua Savage	1
5	Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie’s Disease 2023 ·Urology ·(unknown), (unknown), Joshua Savage, Tobias Köhler, Matthew Ziegelmann, Landon Trost	2
6	Outcomes of collagenase Clostridium histolyticum in men with ventral curvatures: an updated series 2023 ·The Journal of Sexual Medicine ·(unknown), Joshua Savage, (unknown), (unknown), Matthew Ziegelmann, Tobias Köhler, Landon Trost	0
7	Improved Peyronie's Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol 2022 ·Urology ·(unknown), (unknown), (unknown), (unknown), Joshua Savage, (unknown), Sevann Helo, Matthew Ziegelmann, Tobias Köhler, Landon Trost	4
8	Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information 2022 ·Journal of Clinical Epidemiology ·(unknown), Michael J. Grayling, Adrian Mander, Nurulamin M Noor, Joshua Savage, Christina Yap, James Wason	8
9	Protocol for the Tessa Jowell BRAIN MATRIX Platform Study 2022 ·BMJ Open ·Colin Watts, Joshua Savage, Amit Patel, (unknown), Victoria Wykes, Ute Pohl, Helen Bulbeck, John Apps, Rowena Sharpe, Gerard Thompson, Adam Waldman, Olaf Ansorge, Lucinda Billingham	4
10	Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial 2022 ·BMJ Open ·Tobias Menne, Daniel Slade, Joshua Savage, Sadie Johnson, Julie Irving, Pamela Kearns, Ruth Plummer, Geoff Shenton, Gareth J. Veal, Britta Vormoor, Josef Vormoor, Lucinda Billingham	9
11	CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 2021 ·BMJ Open ·Tonny Veenith, Benjamin A. Fisher, Daniel Slade, Anna Rowe, Rowena Sharpe, David Thickett, Tony Whitehouse, Matthew Rowland, James Scriven, Dhruv Parekh, S. Bowden, Joshua Savage, Duncan Richards, Julian Bion, Pamela Kearns, Simon Gates	3
12	Conservative management of suspected fractures in men undergoing collagenase clostridium histolyticum for Peyronie’s Disease is not associated with worsening of erectile function 2020 ·International Journal of Impotence Research ·Kiran Sharma, Raevti Bole, David Y. Yang, Manaf Alom, Joshua Savage, Matthew Ziegelmann, Landon Trost	6
13	Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol 2020 ·BMJ Open ·Anthony Kong, James Good, Amanda Kirkham, Joshua Savage, (unknown), (unknown), Joanna L. Parish, Rachel Spruce, Martin Förster, Stefano Schipani, Kevin J. Harrington, Joseph J. Sacco, (unknown), Gary Middleton, Christina Yap, Hisham Mehanna	26
14	Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial 2020 ·The Lancet Respiratory Medicine ·Gary Middleton, Kristian Brock, Joshua Savage, (unknown), Yvonne Summers, (unknown), Riyaz Shah, Christian H. Ottensmeier, Paul Shaw, Siow Ming Lee, Sanjay Popat, (unknown), Gloria Barone, Lucinda Billingham	113
15	PL02.09 National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC) 2019 ·Journal of Thoracic Oncology ·Gary Middleton, Sanjay Popat, (unknown), Yvonne Summers, Alastair Greystoke, David Gilligan, Judith Cave, N. O’Rourke, A. Brewster, Elizabeth Toy, James Spicer, Joshua Savage, Rowena Sharpe, Timothy A. Yap, Charles Swanton, Lucinda Billingham	1
16	Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men With Ventral Curvatures 2019 ·Urology ·Manaf Alom, Yifan Meng, Kiran Sharma, Joshua Savage, Tobias Köhler, Landon Trost	17
17	Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease 2018 ·Urology ·Kevin Wymer, Matthew Ziegelmann, Joshua Savage, Tobias Köhler, Landon Trost	42
18	Syntaxin 8 Regulates Platelet Dense Granule Secretion, Aggregation, and Thrombus Stability 2014 ·Journal of Biological Chemistry ·(unknown), Matthew T. Harper, Christopher M. Williams, Joshua Savage, Robert Goggs, Gabriele Fischer von Mollard, Alastair W. Poole	29
19	An integrated semicompliant balloon ultrasound catheter for quantitative feedback and image guidance during stent deployment 2005 ·IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control ·(unknown), Joshua Savage, Douglas N. Stephens, M. O’Donnell	3
20	Protective effects of low and high doses of cyclosporin A against reoxygenation injury in isolated rat cardiomyocytes are associated with differential effects on mitochondrial calcium levels 2000 ·Cell Calcium ·Elinor J. Griffiths, Christopher Ocampo, Joshua Savage, Michael D. Stern, Howard S. Silverman	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact